featured
Everolimus, Letrozole, and Trastuzumab in Patients With HR+ Metastatic Breast Cancer or Other Solid Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients With Hormone Receptor-Positive Metastatic Breast Cancer or Other Solid Tumors
Clin. Cancer Res 2020 Oct 28;[EPub Ahead of Print], A Ballhausen, JJ Wheler, DD Karp, SA Piha-Paul, S Fu, S Pant, AM Tsimberidou, DS Hong, V Subbiah, VR Holley, H Huang, AM Brewster, KB Koenig, NK Ibrahim, F Meric-Bernstam, F JankuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.